DHG Pharma

Can Tho, Vietnam Founded: 1974 • Age: 52 yrs Listed Acquired By Taisho Pharmaceutical
Pharmaceutical products are manufactured and distributed in Vietnam.

About DHG Pharma

DHG Pharma is a publicly listed company based in Can Tho (Vietnam) founded in 1974, and was acquired by Taisho Pharmaceutical in April 2019. Pharmaceutical products are manufactured and distributed in Vietnam. DHG Pharma has completed 1 acquisition, including Medicauce. Its website dhgpharma.com.vn draws about 55 thousand monthly visits. DHG Pharma offers products and services including Hapacol and Biofermin and ALFE. Its focus areas include Traditional Pharmaceuticals, Generics and Diversified. Its legal entity is Công ty Cổ phần Dược Hậu Giang.

Company details

DHG Pharma was established in 1974 in Can Tho, Vietnam, within the pharmaceutical sector. A variety of pharmaceutical products is produced and distributed across the region. Community outreach programs centered on health initiatives are conducted regularly. Shareholder transparency is ensured via consistent communications and financial reports. Employee well-being is supported through measures including housing assistance programs.

Key Metrics
  • Annual Revenue
    $5270 B
    7.82
    as on Dec 31, 2025
  • Net Profit
    $824.78 B
    9.45
    as on Dec 31, 2025
  • EBITDA
    $1070 B
    3.82
    as on Dec 31, 2025
  • Latest Funding Round
    $97.2M (USD), Post-IPO

    Jul 2016

  • Investors
  • Investments & Acquisitions
  • Acquired by

Products & Services of DHG Pharma

DHG Pharma offers a comprehensive portfolio of products and services, including Hapacol and Biofermin and ALFE.

Hapacol
Pharmaceutical Products

Medications for health management are produced and supplied by DHG Pharma under this brand.

Biofermin and ALFE
Health Supplements

Nutritional and therapeutic products are distributed by DHG Pharma for community sampling and use.

Apps and channels of DHG Pharma

its YouTube channel DHG Pharma - Vì một cuộc sống khỏe đẹp hơn has 2.43K subscribers and 30 videos.

DHG Pharma - Vì một cuộc sống khỏe đẹp hơn
YouTube 2.43K subscribers 30 videos Entertainment
Open channel

Videos from DHG Pharma

The most watched videos on DHG Pharma's YouTube channel, DHG Pharma - Vì một cuộc sống khỏe đẹp hơn (2.43K subscribers). Click a video to play it here.

Men vi sinh Biofermin - Giải pháp toàn diện cho hệ tiêu hóa khỏe
2.3M views
Collagen ALFE - Có Sắt, Da Khởi Sắc
1.4M views
Biofermin - Ăn gì cũng ngon, chẳng lo đầy bụng
1.3M views
CÓ YUNPRO - TIÊU HÓA KHỎE, NHÀ MÌNH VUI!
1.3M views

More on DHG Pharma - Vì một cuộc sống khỏe đẹp hơn.

Funding Insights of DHG Pharma

  • Total Rounds 1
  • Last Round Post-IPO — $97.2M
  • First Round $97.2M

    (Jul 2016)

  • Investors Count 1

All 1 funding rounds of DHG Pharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jul 2016$97.2MPost-IPO––
Valuation history

2 investors in total: 2 institutional.

Investors in DHG Pharma

DHG Pharma has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Taisho Pharmaceutical and Taisho Holdings.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Over-the-counter and prescription pharmaceutical drugs are manufactured.
1912taisho-holdings.co.jpToshima City, Japan
Pharmaceuticals, supplements, and beauty products are manufactured and distributed internationally.
1912taisho.co.jpToshima City, Japan
Premium access

Investor details for DHG Pharma

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

IPO & Listings of DHG Pharma

DHG Pharma is a publicly listed company on the HOSE with ticker symbol DHG in Vietnam, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date21 Dec 2006
  • Listed onHOSE: DHG
  • Listed entityDHG Pharmaceutical Joint Stock Company
  • Exchange sectorHealth technology
  • ISINVN000000DHG0
  • Share price89,100.00 VND (+0.11% on the day) · 2026-10-14
  • Market capitalisation11,636,399,627,686.00 VND
  • Price to earnings11.8
  • EPS (diluted, trailing year)7,522.72 VND
  • Dividend yield11.24%
  • Volume (last session)3,509

Financials of DHG Pharma

Exchange-reported annual figures
YearRevenueNet incomeEBITDA
20255,270.00B VND824.78B VND1,070.00B VND
20244,880.00B VND753.55B VND1,030.00B VND
20235,020.00B VND1,020.00B VND1,140.00B VND
20224,680.00B VND956.80B VND1,160.00B VND
20214,000.00B VND747.75B VND942.86B VND
Premium access

Detailed financial statements for DHG Pharma

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Investments & Acquisitions by DHG Pharma

DHG Pharma has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Medicauce.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Transfer tables, sleep sheets, and other medical products are provided.
medicauce.com2015Jan 2024••••
Premium access

Complete acquisition details for DHG Pharma

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of DHG Pharma

5 dated milestones of DHG Pharma across 50 years, from founding to its latest funding, stage changes and deals.

  1. Founded DHG Pharma is founded.
  2. IPO Lists on the stock exchange (IPO).
  3. Funding First funding round of $97.2M.
  4. Exit Acquired by Taisho Pharmaceutical.
  5. Acquisition Acquires Medicauce.

Web traffic of DHG Pharma

The website of DHG Pharma (dhgpharma.com.vn) receives about 54.5K visits a month.

  • Monthly visits
    54.5K

    ▲ 9.6% vs previous month

Similar websites

Websites whose visitors overlap most with DHG Pharma. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
domesco.com
100%
8.8K#2,414,481View details
traphaco.com.vn
99%
19.5K#1,451,220View details
rxvietnamstore.com
rxvietnamstore.com
84%
–
imexpharm.com
84%
20.8K#1,053,161View details
vnpca.org.vn
vnpca.org.vn
84%
#9,033,411–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 19 similar websites and full traffic analytics for DHG Pharma

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 19 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about DHG Pharma

DHG Pharma was founded in 1974 and raised its 1st funding round 42 years after it was founded.

DHG Pharma is headquartered in Can Tho, Vietnam.

DHG Pharma was established in 1974 in Can Tho, Vietnam, within the pharmaceutical sector. A variety of pharmaceutical products is produced and distributed across the region. Community outreach programs centered on health initiatives are conducted regularly. Shareholder transparency is ensured via consistent communications and financial reports. Employee well-being is supported through measures including housing assistance programs.

DHG Pharma offers Hapacol and Biofermin and ALFE.

Yes, DHG Pharma is publicly traded on HOSE under the ticker symbol DHG.

DHG Pharma has made 1 acquisition, including Medicauce.

DHG Pharma has 2 investors. Key investors include Taisho Pharmaceutical, and Taisho Holdings.

DHG Pharma operates through Công Ty Cổ Phần Dược Hậu Giang.

Yes. DHG Pharma was acquired by Taisho Pharmaceutical in April 2019.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available